Try new Pen-Strep antibiotic with GlutaMAX supplement, a stable alternative to L-glutamine that enhances cell health. Learn more >
Citations & References (5)
Thermo Scientific™
GlutaMAX™ Supplement
Gibco™ GlutaMAX™ Supplement is an alternative to L-glutamine, with increased stability that improves cell health. GlutaMAX™ Supplement is suitable forRead more
Have Questions?
Change view
Catalog Number
Quantity
35050038
also known as 35050-038
100 mL
35050087
also known as 35050-087
20 x 100 mL
2 Options
Catalog number 35050038
also known as 35050-038
Price (EUR)
90,75
Each
Add to cart
Quantity:
100 mL
Price (EUR)
90,75
Each
Add to cart
Gibco™ GlutaMAX™ Supplement is an alternative to L-glutamine, with increased stability that improves cell health. GlutaMAX™ Supplement is suitable for both adherent and suspension culture of mammalian cells, with no adaptation required. GlutaMAX™ Supplement is offered as a 200 mM L-alanyl-L-glutamine dipeptide in 0.85% NaCl. GlutaMAX™ Supplement is also included in a variety of media formulations. Compared to L-glutamine, GlutaMAX™ Supplement:
Features:
• Minimizes toxic ammonia build-up • Improves cell viability and growth • Remains stable across a wide range of temperatures
Minimizes toxic ammonia build-up Unlike L-glutamine, GlutaMAX™ Supplement does not spontaneously break down to form ammonia. Instead, cells cleave the dipeptide bond to release L-glutamine as needed. This system prevents waste build-up and maintains a fresh supply of L-glutamine during long-term culture.
Improves cell viability and growth Cultures with lower levels of ammonia show improved cell viability. In addition, culture conditions are more controlled due to the consistent concentration of GlutaMAX™ Supplement that is not possible with L-glutamine.
Remains stable across a wide range of temperatures GlutaMAX™ Supplement is room-temperature stable and ready to use. GlutaMAX™ Supplement retains full functionality for 24 months at room temperature, 2 to 8°C, or -5 to -30°C for convenient storage and handling. GlutaMAX™ Supplement is even stable at 37°C for a week or more.
cGMP manufacturing and quality system Gibco™ GlutaMAX™ supplement is manufactured at a cGMP compliant facility, located in Paisley, Scotland. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standard. For supply chain continuity, we offer an identical Gibco™ GlutaMAX™ supplement made in our Grand Island, New York facility (35050-061). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standards.
Storage conditions: 15°C to 30°C Alternate storage conditions: -5°C to -20°C and 2°C to 8°C Shipping conditions: Room temperature Shelf life: 24 months from date of manufacture
Frequently asked questions (FAQs)
Will depletion, absence, or breakdown of essential growth-promoting components such as glutamine or growth factors reduce the growth rate of my culture?
Yes. If you suspect that this is the case, remove the medium and add fresh medium. Alternatively, you can supplement medium with growth-promoting components. It is also possible to substitute GlutaMax I or II for glutamine in the medium to prevent glutamine exhaustion.
Will the media formulations containing GlutaMAX supplement change with respect to L-glutamine content?
In all media containing GlutaMAX supplement dipeptides as a substitute for L-glutamine, concentration is equimolar with the L-glutamine in the original formulation.
What is the difference between Gibco GlutaMAX and glutamine supplements?
GlutaMAX Supplement is an improved cell culture supplement that can be used as a direct substitute for L-glutamine in your cell culture medium. Please go here to read more about the properties of GlutaMAX supplement (https://www.thermofisher.com/us/en/home/life-science/cell-culture/mammalian-cell-culture/media-supplements/glutamax-media/glutamax-vs-glutamine.html).
Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy
Authors:Meghan Logun, Xin Wang, Yusha Sun, Stephen J Bagley, Nannan Li, Arati Desai, Daniel Y Zhang, MacLean P Nasrallah, Emily Ling-Lin Pai, Bike Su Oner, Gabriela Plesa, Donald Siegel, Zev A Binder, Guo-Li Ming, Hongjun Song, Donald M O'Rourke
Journal:Cell Stem Cell
PubMed ID:39657679
Patient-derived tumor organoids have been leveraged for disease modeling and preclinical studies but rarely applied in real time to aid with interpretation of patient treatment responses in clinics. We recently demonstrated early efficacy signals in a first-in-human, phase 1 study of dual-targeting chimeric antigen receptor (CAR)-T cells (EGFR-IL13Rα2 CAR-T cells) ... More
A comprehensive protocol for efficient differentiation of human NPCs into electrically competent neurons.
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors.
Authors:Kutner RH, Zhang XY, Reiser J,
Journal:Nat Protoc
PubMed ID:19300443
'Over the past decade, lentiviral vectors have emerged as powerful tools for transgene delivery. The use of lentiviral vectors has become commonplace and applications in the fields of neuroscience, hematology, developmental biology, stem cell biology and transgenesis are rapidly emerging. Also, lentiviral vectors are at present being explored in the ... More
IDH mutation impairs histone demethylation and results in a block to cell differentiation.
Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in gliomas, acute myeloid leukaemias (AML) and chondrosarcomas, and share a novel enzymatic property of producing 2-hydroxyglutarate (2HG) from a-ketoglutarate. Here we report that 2HG-producing IDH mutants can prevent the histone demethylation that is required for lineage-specific progenitor ... More
Characterization of pluripotent stem cells.
Authors:Martí M, Mulero L, Pardo C, Morera C, Carrió M, Laricchia-Robbio L, Esteban CR, Izpisua Belmonte JC,
Journal:Nat Protoc
PubMed ID:23306458
Characterization of pluripotent stem cells is required for the registration of stem cell lines and allows for an impartial and objective comparison of the results obtained when generating multiple lines. It is therefore crucial to establish specific, fast and reliable protocols to detect the hallmarks of pluripotency. Such protocols should ... More